<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Rasagiline</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Rasagiline">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Rasagiline</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Rasagiline</b> (<b>Azilect, Azipron</b>) is an irreversible inhibitor of monoamine oxidase-B<span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.<span class="mw-ref" id="cite_ref-pmid18547126_3-0"><a href="#cite_note-pmid18547126-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Rasagiline</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Rasagiline2DCSD.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rasagiline2DCSD.svg.png" data-file-width="512" data-file-height="527" data-file-type="drawing" height="154" width="150"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Rasagiline3DanJ.gif" tppabs="https://ptable.com/wiki/compounds/I/m/Rasagiline3DanJ.gif" data-file-width="539" data-file-height="260" data-file-type="bitmap" height="121" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Azilect, Azipron, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>VP-1012, N-propargyl-1(R)-aminoindan<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/azilect.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/azilect.html'" tppabs="https://www.drugs.com/monograph/azilect.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a606017.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a606017.html'" tppabs="https://medlineplus.gov/druginfo/meds/a606017.html" class="external text external">a606017</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Rasagiline  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Rasagiline'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Rasagiline" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Rasagiline&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Rasagiline&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Rasagiline&SearchType=BasicSearch" class="external text external">Rasagiline</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B3<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>C (Risk not ruled out)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N04BD02<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N04BD02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N04BD02'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N04BD02" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>36%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>88<span>&nbsp;</span>– 94%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (CYP1A2-mediated)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>3 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Kidney and fecal</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(<i>R</i>)-<i>N</i>-(prop-2-ynyl)-2,3-dihydro-1<i>H</i>-inden-1-amine</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=136236-51-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=136236-51-6'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=136236-51-6" class="external text external">136236-51-6</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/3052776  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/3052776'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/3052776" class="external text external">3052776</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6641  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6641'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6641" class="external text external">6641</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01367  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01367'" tppabs="https://www.drugbank.ca/drugs/DB01367" class="external text external">DB01367</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.2314553.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.2314553.html'" tppabs="http://www.chemspider.com/Chemical-Structure.2314553.html" class="external text external">2314553</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=003N66TS6T  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=003N66TS6T'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=003N66TS6T" class="external text external">003N66TS6T</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D02562  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D02562'" tppabs="https://www.kegg.jp/entry/D02562" class="external text external">D02562</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL887  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL887'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL887" class="external text external">ChEMBL887</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>RAS (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RAS  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RAS'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RAS" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RAS&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RAS&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RAS&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID3041112  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID3041112'" tppabs="https://comptox.epa.gov/dashboard/DTXSID3041112" class="external text external">DTXSID3041112</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>12</sub><span>H</span><sub>13</sub><span>N</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">171.243</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=C%23CCN%5BC%40H%5D2c1ccccc1CC2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=C%23CCN%5BC%40H%5D2c1ccccc1CC2'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=C%23CCN%5BC%40H%5D2c1ccccc1CC2" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">C#CCN[C@H]2c1ccccc1CC2</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:RUOKEQAAGRXIBM-GFCCVEGCSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464380249&page2=Rasagiline  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464380249&page2=Rasagiline'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464380249&page2=Rasagiline" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identified it as a potential drug for Parkinson's disease, and working with collaborators at  Technion<span>&nbsp;</span>– Israel Institute of Technology in Israel and the drug company, Teva Pharmaceutical, identified the R-isomer as the active form of the drug.<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Teva brought it to market in partnership with Lundbeck in Europe and Eisai in the US and elsewhere. It was approved in Europe in 2005 and in the US in 2006.</p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_use">Medical use</h2></summary>
    
<p>Rasagiline is used to treat symptoms of Parkinson's disease both alone and in combination with other drugs. It has shown efficacy in both early and advanced Parkinsons, and appears to be especially useful in dealing with non-motor symptoms like fatigue.<span class="mw-ref" id="cite_ref-2015RevExpertOpin_5-0"><a href="#cite_note-2015RevExpertOpin-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-Cochrane2015Fatigue_6-0"><a href="#cite_note-Cochrane2015Fatigue-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Label_7-0"><a href="#cite_note-Label-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>

<p>Rasagiline has not been tested in pregnant women and is Pregnancy Category C in the US.<span class="mw-ref" id="cite_ref-Label_7-1"><a href="#cite_note-Label-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>The FDA label contains warnings that rasagiline may cause severe hypertension or hypotension, may make people sleepy, may make motor control worse in some people, may cause hallucinations and psychotic-like behavior, may cause impulse control disorder, may increase the risk of melanoma, and upon withdrawal may cause high fever or confusion.<span class="mw-ref" id="cite_ref-Label_7-2"><a href="#cite_note-Label-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>

<p>Side effects when the drug is taken alone include flu-like symptoms, joint pain, depression, stomach upset, headache, dizziness, and insomnia. When taken with <a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA">L-DOPA</a>, side effects include increased movement problems, accidental injury, sudden drops in blood pressure,  joint pain and swelling, dry mouth, rash, abnormal dreams and digestive problems including vomiting, loss of appetite, weight loss, abdominal pain, nausea, constipation.<span class="mw-ref" id="cite_ref-Label_7-3"><a href="#cite_note-Label-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span>  When taken with Parkinson's drugs other than L-DOPA, side effects include peripheral edema, fall, joint pain, cough, and insomnia.<span class="mw-ref" id="cite_ref-Label_7-4"><a href="#cite_note-Label-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Interactions">Interactions</h3></summary>
    
<p>People who are taking <a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meperidine" title="Meperidine" class="mw-redirect">meperidine</a>, <a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">tramadol</a>, <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a>, propoxyphene, <a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">dextromethorphan</a>, St. John’s wort, <a href="Cyclobenzaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclobenzaprine" title="Cyclobenzaprine">cyclobenzaprine</a>, or another  MAO inhibitor should not take rasagiline.<span class="mw-ref" id="cite_ref-Label_7-5"><a href="#cite_note-Label-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>

<p>The FDA drug label carries a warning of the risk of serotonin syndrome when rasagiline is used with antidepressants or with <a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meperidine" title="Meperidine" class="mw-redirect">meperidine</a>.<span class="mw-ref" id="cite_ref-Label_7-6"><a href="#cite_note-Label-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span>  However the risk appears to be low, based on a multicenter retrospective study in 1504 people, which looked for serotonin syndrome in people with PD who were treated with rasagiline plus antidepressants, rasagiline without antidepressants, or antidepressants plus Parkinson's drugs other than either rasagiline or selegiline; no cases were identified.<span class="mw-ref" id="cite_ref-2015RevExpertOpin_5-1"><a href="#cite_note-2015RevExpertOpin-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>

<p>There is a risk of psychosis or bizarre behavior if rasagiline is used with dextromethorphan and there is a risk of non-selective MAO inhibition and hypertensive crisis if rasagiline is used with other MAO inhibitors.<span class="mw-ref" id="cite_ref-Label_7-7"><a href="#cite_note-Label-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>Rasagiline is molecularly a <a href="Propargyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Propargyl" title="Propargyl">propargyl</a>amine derivative.<span class="mw-ref" id="cite_ref-OrgChemDD2014_8-0"><a href="#cite_note-OrgChemDD2014-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span>  The form brought to market by Teva and its partners is the mesylate salt, and was  designated chemically as: 1H-Inden-1-amine-2,3-dihydro-N-2-propynyl-(1R)-methanesulfonate.<span class="mw-ref" id="cite_ref-Label_7-8"><a href="#cite_note-Label-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanism_of_action">Mechanism of action</h3></summary>
    
<p>Parkinson's disease is characterized by the death of cells that produce <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a>, a neurotransmitter. An enzyme called monoamine oxidase (MAO) breaks down neurotransmitters.  MAO has two forms, MAO-A and MAO-B.  MAO-B breaks down  <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a>.  Rasagiline prevents the breakdown of dopamine by irreversibly binding to MAO-B. Dopamine is therefore more available, somewhat compensating for the diminished quantities made in the brains of people with Parkinson's.<span class="mw-ref" id="cite_ref-2015RevExpertOpin_5-2"><a href="#cite_note-2015RevExpertOpin-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>

<p><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a> was the first selective MAO-B inhibitor.  It is partly metabolized to levomethamphetamine (l-methamphetamine), one of the two enantiomers of <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>, <i>in vivo</i>.<span class="mw-ref" id="cite_ref-Pmid_9-0"><a href="#cite_note-Pmid-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-Foye2012_10-0"><a href="#cite_note-Foye2012-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> While these metabolites may contribute to selegiline's ability to inhibit reuptake of the neurotransmitters dopamine and norepinephrine, they have also been associated with orthostatic hypotension and hallucinations in some people.<span class="mw-ref" id="cite_ref-Foye2012_10-1"><a href="#cite_note-Foye2012-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Rasagiline metabolizes into 1(<i>R</i>)-aminoindan which has no amphetamine-like characteristics<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> and has neuroprotective properties in cells and in animal models.<span class="mw-ref" id="cite_ref-NRDD2005_14-0"><a href="#cite_note-NRDD2005-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>It is selective for MAO type B over type A by a factor of fourteen.<span class="mw-ref" id="cite_ref-pmid16366596_15-0"><a href="#cite_note-pmid16366596-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Metabolism">Metabolism</h3></summary>
    
<p>Rasagiline is broken down via CYP1A2,<span class="mw-ref" id="cite_ref-pmid18488080_16-0"><a href="#cite_note-pmid18488080-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> part of the cytochrome P450 metabolic path in the liver. It is contraindicated in patients with hepatic insufficiency and its use should be monitored carefully in patients taking other drugs that alter the normal effectiveness of this metabolic path.<span class="mw-ref" id="cite_ref-Label_7-9"><a href="#cite_note-Label-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Racemic rasagiline was discovered and patented by Aspro Nicholas in the 1970s as a drug candidate for treatment of hypertension.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>Moussa Youdim, a biochemist, had been involved in developing <a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">selegiline</a> as a drug for Parkinsons, in collaboration with Peter Reiderer.  He wanted to find a similar compound that would have fewer side effects, and around 1977, at about the same time he moved from London to Haifa to join the faculty of Technion, he noticed that rasagiline could potentially be such a compound.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> He called that compound, AGN 1135.<span class="mw-ref" id="cite_ref-Finberg1996_19-0"><a href="#cite_note-Finberg1996-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>In 1996 Youdim, in collaboration with scientists from Technion and the US National Institutes of Health, and using compounds developed with Teva Pharmaceutical, published a paper in which the authors wrote that they were inspired by the racemic nature of deprenyl and the greater activity of one of its steroisomers, L-deprenyl, which became <a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">selegiline</a>,  to explore the qualities of the isomers of the Aspro compound, and they found that the R-isomer had almost all the activity; this is the compound that became rasagiline.<span class="mw-ref" id="cite_ref-Finberg1996_19-1"><a href="#cite_note-Finberg1996-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span>  They called the mesylate salt of the R-isomer TVP-1012 and the hydrochloride salt, TVP-101.<span class="mw-ref" id="cite_ref-Finberg1996_19-2"><a href="#cite_note-Finberg1996-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>Teva and Technion filed patent applications for this racemically pure compound, methods to make it, and methods to use it to treat Parkinsons and other disorders, and Technion eventually assigned its rights to Teva.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>Teva began development of rasagiline, and by 1999 was in Phase III trials, and entered into a partnership with Lundbeck in which Lundbeck agreed to share the costs and obtained the joint right to market the drug in Europe.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span>  In 2003 Teva partnered with Eisai, giving Eisai the right to jointly market the drug for Parkinson's in the US, and to co-develop and co-market the drug for Alzheimers and other neurological diseases.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>It was approved by the European Medicines Agency for Parkinson's in 2005<span class="mw-ref" id="cite_ref-NRDD2005_14-1"><a href="#cite_note-NRDD2005-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> and in the US in 2006.<span class="mw-ref" id="cite_ref-OrgChemDD2014_8-1"><a href="#cite_note-OrgChemDD2014-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>255</span></sup></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Rasagiline was tested for efficacy in people with multiple system atrophy in a large randomized, placebo-controlled, double-blind disease-modification trial; the drug failed.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>

<p>Teva conducted clinical trials attempting to prove that rasagiline did not just treat symptoms, but was a disease-modifying drug - that it actually prevented the death of the dopaminergic neurons that characterize Parkinson's disease and slowed disease progression.  They conducted two clinical trials, called TEMPO and ADAGIO, to try to prove this.  The FDA advisory committee rejected their claim in 2011, saying that the clinical trial results did not prove that rasagiline was neuroprotective. The main reason was that in one of the trials, the lower dose was effective at slowing progression, but the higher dose was not, and this made no sense in light of standard dose-response pharmacology.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a></li>
<li>Ladostigil</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite id="CITEREFAkao2002" class="citation journal cs1">Akao, Y;  et al. (2002). "An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells". <i>Neurosci Lett</i>. <b>326</b> (2): 105–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0304-3940%2802%2900332-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0304-3940%2802%2900332-4'" tppabs="https://doi.org/10.1016%2Fs0304-3940%2802%2900332-4" class="external text external">10.1016/s0304-3940(02)00332-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12057839  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12057839'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12057839" class="external text external">12057839</a>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite id="CITEREFOldfieldKeatingPerry2007" class="citation journal cs1">Oldfield V, Keating GM, Perry CM (2007). "Rasagiline: a review of its use in the management of Parkinson's disease". <i>Drugs</i>. <b>67</b> (12): 1725–47. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200767120-00006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200767120-00006'" tppabs="https://doi.org/10.2165%2F00003495-200767120-00006" class="external text external">10.2165/00003495-200767120-00006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17683172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17683172'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17683172" class="external text external">17683172</a>.</cite></span></li><li id="cite_note-pmid18547126-3"> <span id="mw-reference-text-cite_note-pmid18547126-3" class="mw-reference-text"><cite id="CITEREFGallagherSchrag2008" class="citation journal cs1">Gallagher DA, Schrag A (2008). "Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease". <i>CNS Drugs</i>. <b>22</b> (7): 563–86. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00023210-200822070-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00023210-200822070-00003'" tppabs="https://doi.org/10.2165%2F00023210-200822070-00003" class="external text external">10.2165/00023210-200822070-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18547126  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18547126'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18547126" class="external text external">18547126</a>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFLakhan_SE2007" class="citation journal cs1">Lakhan SE (2007). <a href="javascript:if(confirm('http://www.molecularneurodegeneration.com/content/pdf/1750-1326-2-13.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.molecularneurodegeneration.com/content/pdf/1750-1326-2-13.pdf'" tppabs="http://www.molecularneurodegeneration.com/content/pdf/1750-1326-2-13.pdf" class="external text external">"From a Parkinson's disease expert: Rasagiline and the Future of Therapy"</a> <span class="cs1-format">(PDF)</span>. <i>Molecular Neurodegeneration</i>. <b>2</b> (1): 13–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1750-1326-2-13  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1750-1326-2-13'" tppabs="https://doi.org/10.1186%2F1750-1326-2-13" class="external text external">10.1186/1750-1326-2-13</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929084  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929084'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929084" class="external text external">1929084</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17617893  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17617893'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17617893" class="external text external">17617893</a>.</cite></span></li><li id="cite_note-2015RevExpertOpin-5"> <span id="mw-reference-text-cite_note-2015RevExpertOpin-5" class="mw-reference-text"><cite id="CITEREFStocchiFossati2015" class="citation journal cs1">Stocchi, F; Fossati, C Torti M (2015). "Rasagiline for the treatment of Parkinson's disease: an update". <i>Expert Opin Pharmacother</i>. <b>16</b> (14): 2231–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.2015.1086748  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.2015.1086748'" tppabs="https://doi.org/10.1517%2F14656566.2015.1086748" class="external text external">10.1517/14656566.2015.1086748</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26364897  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26364897'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26364897" class="external text external">26364897</a>.</cite></span></li><li id="cite_note-Cochrane2015Fatigue-6"> <span id="mw-reference-text-cite_note-Cochrane2015Fatigue-6" class="mw-reference-text"><cite id="CITEREFElbers2015" class="citation journal cs1">Elbers, RG;  et al. (Oct 2015). "Interventions for fatigue in Parkinson's disease". <i>Cochrane Database Syst Rev</i>. <b>10</b>: CD010925. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fmds.26334  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fmds.26334'" tppabs="https://doi.org/10.1002%2Fmds.26334" class="external text external">10.1002/mds.26334</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26227071  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26227071'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26227071" class="external text external">26227071</a>.</cite></span></li><li id="cite_note-Label-7"> <span id="mw-reference-text-cite_note-Label-7" class="mw-reference-text"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021641s016s017lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021641s016s017lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021641s016s017lbl.pdf" class="external text external">Azilect Prescribing Information</a> Label last revised May, 2014</span></li><li id="cite_note-OrgChemDD2014-8"> <span id="mw-reference-text-cite_note-OrgChemDD2014-8" class="mw-reference-text">Richard B. Silverman, Mark W. Holladay.  The Organic Chemistry of Drug Design and Drug Action, 3rd Edition. Academic Press, 2014 ISBN<span>&nbsp;</span>9780123820310</span></li><li id="cite_note-Pmid-9"> <span id="mw-reference-text-cite_note-Pmid-9" class="mw-reference-text"><cite id="CITEREFEngbergElebringNissbrandt1991" class="citation journal cs1">Engberg, G; Elebring, T; Nissbrandt, H (1991). "Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>259</b> (2): 841–7. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1658311  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1658311'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1658311" class="external text external">1658311</a>.</cite></span></li><li id="cite_note-Foye2012-10"> <span id="mw-reference-text-cite_note-Foye2012-10" class="mw-reference-text"><cite id="CITEREFLemkeWilliams2012" class="citation book cs1">Lemke, Thomas L.; Williams, David A, eds. (2012). <i>Foye's Principles of Medicinal Chemistry</i>. Lippincott Williams &amp; Wilkins. p.<span>&nbsp;</span>434. ISBN<span>&nbsp;</span><bdi>978-1609133450</bdi>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFBar_AmAmitYoudim2004" class="citation journal cs1">Bar Am, Orit; Amit, Tamar; Youdim, Moussa B. H. (2004-01-30). "Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline". <i>Neuroscience Letters</i>. <b>355</b> (3): 169–172. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.neulet.2003.10.067  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.neulet.2003.10.067'" tppabs="https://doi.org/10.1016%2Fj.neulet.2003.10.067" class="external text external">10.1016/j.neulet.2003.10.067</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0304-3940  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0304-3940'" tppabs="https://www.worldcat.org/issn/0304-3940" class="external text external">0304-3940</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14732458  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14732458'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14732458" class="external text external">14732458</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFYasarGoldbergGoldberg1996" class="citation journal cs1">Yasar, S.; Goldberg, J. P.; Goldberg, S. R. (1996-01-01). "Are metabolites of l-deprenyl (selegiline) useful or harmful? Indications from preclinical research". <i>Journal of Neural Transmission. Supplementum</i>. <b>48</b>: 61–73. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0303-6995  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0303-6995'" tppabs="https://www.worldcat.org/issn/0303-6995" class="external text external">0303-6995</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8988462  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8988462'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8988462" class="external text external">8988462</a>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFChenSwope2005" class="citation journal cs1">Chen JJ, Swope DM (2005). <a href="javascript:if(confirm('https://archive.is/20120711214831/http://jcp.sagepub.com/cgi/pmidlookup?view=long&pmid=16027398  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.is/20120711214831/http://jcp.sagepub.com/cgi/pmidlookup?view=long&pmid=16027398'" tppabs="https://archive.is/20120711214831/http://jcp.sagepub.com/cgi/pmidlookup?view=long&pmid=16027398" class="external text external">"Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease"</a>. <i>J Clin Pharmacol</i>. <b>45</b> (8): 878–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0091270005277935  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0091270005277935'" tppabs="https://doi.org/10.1177%2F0091270005277935" class="external text external">10.1177/0091270005277935</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16027398  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16027398'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16027398" class="external text external">16027398</a>. Archived from <a href="javascript:if(confirm('http://jcp.sagepub.com/cgi/pmidlookup?view=long&pmid=16027398  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jcp.sagepub.com/cgi/pmidlookup?view=long&pmid=16027398'" tppabs="http://jcp.sagepub.com/cgi/pmidlookup?view=long&pmid=16027398" class="external text external">the original</a> on 2012-07-11<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-08-18</span></span>.</cite></span></li><li id="cite_note-NRDD2005-14"> <span id="mw-reference-text-cite_note-NRDD2005-14" class="mw-reference-text"><cite id="CITEREFSchapiraBateKirkpatrick2005" class="citation journal cs1">Schapira, A; Bate, G; Kirkpatrick, P (Aug 2005). "Fresh from the Peiple: Rasagiline". <i>Nat Rev Drug Discov</i>. <b>4</b> (8): 625–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrd1803  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrd1803'" tppabs="https://doi.org/10.1038%2Fnrd1803" class="external text external">10.1038/nrd1803</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16106586  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16106586'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16106586" class="external text external">16106586</a>.</cite></span></li><li id="cite_note-pmid16366596-15"> <span id="mw-reference-text-cite_note-pmid16366596-15" class="mw-reference-text"><cite id="CITEREFBindaHubálekLiHerzig2005" class="citation journal cs1">Binda C, Hubálek F, Li M, Herzig Y, Sterling J, Edmondson DE, Mattevi A (2005). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519603  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519603'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519603" class="external text external">"Binding of Rasagiline-related Inhibitors to Human Monoamine Oxidases: A Kinetic and Crystallographic Analysis"</a>. <i>Journal of Medicinal Chemistry</i>. <b>48</b> (26): 8148–54. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjm0506266  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjm0506266'" tppabs="https://doi.org/10.1021%2Fjm0506266" class="external text external">10.1021/jm0506266</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519603  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519603'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519603" class="external text external">2519603</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16366596  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16366596'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16366596" class="external text external">16366596</a>.</cite></span></li><li id="cite_note-pmid18488080-16"> <span id="mw-reference-text-cite_note-pmid18488080-16" class="mw-reference-text"><cite id="CITEREFLechtHaroutiunianHoffmanLazarovici2007" class="citation journal cs1">Lecht S, Haroutiunian S, Hoffman A, Lazarovici P (2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386362  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386362'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386362" class="external text external">"Rasagiline – a novel MAO B inhibitor in Parkinson's disease therapy"</a>. <i>Ther Clin Risk Manag</i>. <b>3</b> (3): 467–74. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386362  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386362'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386362" class="external text external">2386362</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18488080  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18488080'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18488080" class="external text external">18488080</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><a href="javascript:if(confirm('https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3513244.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3513244.pdf'" tppabs="https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3513244.pdf" class="external text external">US 3,513,244</a>.  See <a href="javascript:if(confirm('https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5453446.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5453446.pdf'" tppabs="https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5453446.pdf" class="external text external">US patent 5453446</a>, lines 50-60.  US Patent 5453446 was the patent at issue in <a href="javascript:if(confirm('https://www.pharmamedtechbi.com/~/media/Supporting%20Documents/The%20Pink%20Sheet%20DAILY/2013/September/Teva%20Neuroscience%20v%20Watson%20opinion%20092013.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pharmamedtechbi.com/~/media/Supporting%20Documents/The%20Pink%20Sheet%20DAILY/2013/September/Teva%20Neuroscience%20v%20Watson%20opinion%20092013.pdf'" tppabs="https://www.pharmamedtechbi.com/~/media/Supporting%20Documents/The%20Pink%20Sheet%20DAILY/2013/September/Teva%20Neuroscience%20v%20Watson%20opinion%20092013.pdf" class="external text external">Teva v Watson</a>, see page 2</span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text">Judy Sielg-Itzkovich for the Jerusalem Post. November 13, 2010. <a href="javascript:if(confirm('http://www.jpost.com/Health-and-Sci-Tech/Health/Making-armor-for-the-brain  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.jpost.com/Health-and-Sci-Tech/Health/Making-armor-for-the-brain'" tppabs="http://www.jpost.com/Health-and-Sci-Tech/Health/Making-armor-for-the-brain" class="external text external">Making armor for the brain</a></span></li><li id="cite_note-Finberg1996-19"> <span id="mw-reference-text-cite_note-Finberg1996-19" class="mw-reference-text"><cite id="CITEREFFinbergLamensdorfCommissiongYoudim1996" class="citation journal cs1">Finberg, JP; Lamensdorf, I; Commissiong, JW; Youdim, MB (1996). "Pharmacology and neuroprotective properties of rasagiline. Pharmacology and neuroprotective properties of rasagiline". <i>J Neural Transm Suppl</i>. <b>48</b>: 95–101. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8988465  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8988465'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8988465" class="external text external">8988465</a>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><a href="javascript:if(confirm('https://www.pharmamedtechbi.com/~/media/Supporting%20Documents/The%20Pink%20Sheet%20DAILY/2013/September/Teva%20Neuroscience%20v%20Watson%20opinion%20092013.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pharmamedtechbi.com/~/media/Supporting%20Documents/The%20Pink%20Sheet%20DAILY/2013/September/Teva%20Neuroscience%20v%20Watson%20opinion%20092013.pdf'" tppabs="https://www.pharmamedtechbi.com/~/media/Supporting%20Documents/The%20Pink%20Sheet%20DAILY/2013/September/Teva%20Neuroscience%20v%20Watson%20opinion%20092013.pdf" class="external text external">Teva v Watson</a>, see page 2</span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFRasagiline2002" class="citation journal cs1">Rasagiline, Kupsch A (May 2002). "Teva Pharmaceutical". <i>Curr Opin Investig Drugs</i>. <b>3</b> (5): 794–7. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12090555  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12090555'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12090555" class="external text external">12090555</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><a href="javascript:if(confirm('http://www.eisai.com/news/news200312.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.eisai.com/news/news200312.html'" tppabs="http://www.eisai.com/news/news200312.html" class="external text external">Eisai Press Release</a>.  May 15, 2003</span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFPoeweMahlknechtKrismer2015" class="citation journal cs1">Poewe, W; Mahlknecht, P; Krismer, F (2015). "Therapeutic advances in multiple system atrophy and progressive supranuclear palsy". <i>Mov. Disord</i>. <b>30</b>: 1528–38. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fmds.26334  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fmds.26334'" tppabs="https://doi.org/10.1002%2Fmds.26334" class="external text external">10.1002/mds.26334</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26227071  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26227071'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26227071" class="external text external">26227071</a>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text">Vadim Sviderski for Reuters and Haaretz.  Oct 19, 2011 <a href="javascript:if(confirm('http://www.haaretz.com/israel-news/business/fda-advisers-refuse-teva-plea-to-expand-azilect-label-1.390889  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.haaretz.com/israel-news/business/fda-advisers-refuse-teva-plea-to-expand-azilect-label-1.390889'" tppabs="http://www.haaretz.com/israel-news/business/fda-advisers-refuse-teva-plea-to-expand-azilect-label-1.390889" class="external text external">FDA Advisers Refuse Teva Plea to Expand Azilect Label</a></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFRussel_Katz,_M.D." class="citation web cs1">Russel Katz, M.D.;  et al. <a href="javascript:if(confirm('https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM275474.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM275474.pdf'" tppabs="https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM275474.pdf" class="external text external">"Peripheral and Central Nervous System Advisory Committee Background Package on Azilect"</a> <span class="cs1-format">(PDF)</span>. FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">December 7,</span> 2011</span>.</cite></span></li></ol></div>

<div role="navigation" class="navbox" aria-labelledby="Antiparkinson_agents_(N04)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antiparkinson_agents_(N04)" style="font-size:114%;margin:0 4em">Antiparkinson agents (N04)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Dopaminergics</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">DA</a> precursors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA">Levodopa</a><sup>#</sup></li>
<li>Melevodopa</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">DA receptor agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Apomorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Apomorphine" title="Apomorphine">Apomorphine</a></li>
<li><a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">Bromocriptine</a></li>
<li><a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">Cabergoline</a></li>
<li>Dihydroergocryptine</li>
<li><a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">Lisuride</a></li>
<li><a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">Pergolide</a></li>
<li>Piribedil</li>
<li>Pramipexole</li>
<li><a href="Ropinirole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ropinirole" title="Ropinirole">Ropinirole</a></li>
<li>Rotigotine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">MAO-B inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Rasagiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li>Safinamide</li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">COMT inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Entacapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Entacapone" title="Entacapone">Entacapone</a></li>
<li>Opicapone</li>
<li><a href="Tolcapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolcapone" title="Tolcapone">Tolcapone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">AAAD inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Benserazide</li>
<li><a href="Carbidopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbidopa" title="Carbidopa">Carbidopa</a><sup>#</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anticholinergics</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Benzatropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzatropine" title="Benzatropine">Benzatropine</a></li>
<li><a href="Biperiden.htm" tppabs="https://ptable.com/wiki/compounds/A/Biperiden" title="Biperiden">Biperiden</a><sup>#</sup></li>
<li>Bornaprine</li>
<li>Chlorphenoxamine</li>
<li><a href="Cycrimine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cycrimine" title="Cycrimine">Cycrimine</a></li>
<li>Dexetimide</li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li>Etanautine</li>
<li>Etybenzatropine</li>
<li>Mazaticol</li>
<li><a href="Metixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Metixene" title="Metixene">Metixene</a></li>
<li><a href="Orphenadrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Orphenadrine" title="Orphenadrine">Orphenadrine</a></li>
<li>Phenglutarimide</li>
<li>Piroheptine</li>
<li><a href="Procyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procyclidine" title="Procyclidine">Procyclidine</a></li>
<li><a href="Profenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Profenamine" title="Profenamine">Profenamine</a></li>
<li><a href="Trihexyphenidyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Trihexyphenidyl" title="Trihexyphenidyl">Trihexyphenidyl</a></li>
<li>Tropatepine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li>Budipine</li>
<li><a href="Xanthine.htm" tppabs="https://ptable.com/wiki/compounds/A/Xanthine" title="Xanthine">Methylxanthines</a> (e.g., <a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">caffeine</a>)</li>
<li><a href="Rimantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimantadine" title="Rimantadine">Rimantadine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Antioxidants" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antioxidants" style="font-size:114%;margin:0 4em">Antioxidants</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Food antioxidants</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>6-Hydroxymelatonin</li>
<li><a href="Acetylcarnitine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcarnitine" title="Acetylcarnitine">Acetyl-<small>L</small>-carnitine</a> (ALCAR)</li>
<li><a href="Lipoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Lipoic_acid" title="Lipoic acid">Alpha-lipoic acid</a> (ALA)</li>
<li><a href="Vitamin_C.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_C" title="Vitamin C">Ascorbic acid</a> (vitamin C)</li>
<li>Carotenoids (<a href="Vitamin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_A" title="Vitamin A">vitamin A</a>)</li>
<li><a href="Curcumin.htm" tppabs="https://ptable.com/wiki/compounds/A/Curcumin" title="Curcumin">Curcumin</a></li>
<li><a href="Edaravone.htm" tppabs="https://ptable.com/wiki/compounds/A/Edaravone" title="Edaravone">Edaravone</a></li>
<li>Polyphenols</li>
<li><a href="Glutathione.htm" tppabs="https://ptable.com/wiki/compounds/A/Glutathione" title="Glutathione">Glutathione</a></li>
<li>Hydroxytyrosol</li>
<li><a href="Carnitine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carnitine" title="Carnitine"><small>L</small>-carnitine</a></li>
<li>Ladostigil</li>
<li><a href="Melatonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Melatonin" title="Melatonin">Melatonin</a></li>
<li>Mofegiline</li>
<li><a href="Acetylcysteine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcysteine" title="Acetylcysteine"><i>N</i>-Acetylcysteine</a> (NAC)</li>
<li><a href="N-Acetylserotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylserotonin" title="N-Acetylserotonin"><i>N</i>-Acetylserotonin</a> (NAS)</li>
<li>Oleocanthal</li>
<li><a href="Oleuropein.htm" tppabs="https://ptable.com/wiki/compounds/A/Oleuropein" title="Oleuropein">Oleuropein</a></li>
<li><a href="Rasagiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Resveratrol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Resveratrol'" tppabs="https://ptable.com/wiki/compounds/A/Resveratrol" title="Resveratrol">Resveratrol</a></li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a></li>
<li>Selenium</li>
<li>Tocopherols (<a href="Vitamin_E.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_E" title="Vitamin E">vitamin E</a>)</li>
<li>Tocotrienols (<a href="Vitamin_E.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_E" title="Vitamin E">vitamin E</a>)</li>
<li><a href="Tyrosol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosol" title="Tyrosol">Tyrosol</a></li>
<li><a href="Coenzyme_Q10.htm" tppabs="https://ptable.com/wiki/compounds/A/Coenzyme_Q10" title="Coenzyme Q10">Ubiquinone</a> (coenzyme Q)</li>
<li><a href="Uric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Uric_acid" title="Uric acid">Uric acid</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Fuel antioxidants</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Butylated_hydroxytoluene.htm" tppabs="https://ptable.com/wiki/compounds/A/Butylated_hydroxytoluene" title="Butylated hydroxytoluene">Butylated hydroxytoluene</a></li>
<li><a href="2,6-Di-tert-butylphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C6-Di-tert-butylphenol" title="2,6-Di-tert-butylphenol">2,6-Di-<i>tert</i>-butylphenol</a></li>
<li><a href="1,2-Diaminopropane.htm" tppabs="https://ptable.com/wiki/compounds/A/1%2C2-Diaminopropane" title="1,2-Diaminopropane">1,2-Diaminopropane</a></li>
<li><a href="2,4-Dimethyl-6-tert-butylphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C4-Dimethyl-6-tert-butylphenol" title="2,4-Dimethyl-6-tert-butylphenol">2,4-Dimethyl-6-<i>tert</i>-butylphenol</a></li>
<li><a href="Ethylenediamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylenediamine" title="Ethylenediamine">Ethylenediamine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Measurements</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Folin method</li>
<li>ORAC</li>
<li>TEAC</li>
<li>FRAP</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Monoamine_metabolism_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Monoamine_metabolism_modulators" style="font-size:114%;margin:0 4em">Monoamine metabolism modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Non-specific</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>AAAD</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a>→<a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li><a href="5-Hydroxytryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/5-HTP" title="5-HTP" class="mw-redirect">5-HTP</a>→<a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a></li>
<li><small>L</small>-Histidine→<a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine">Phenylalanine</a>→<a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><small>L</small>-Tyrosine→<a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">Tyramine</a></li>
<li><a href="Tryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptophan" title="Tryptophan">Tryptophan</a>→<a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">Tryptamine</a></li></ul>

<ul><li><b>Inhibitors:</b> Benserazide</li>
<li><a href="Carbidopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbidopa" title="Carbidopa">Carbidopa</a></li>
<li>DFMD</li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li>
<li><a href="Methyldopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyldopa" title="Methyldopa">Methyldopa</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>MAO</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products (with <abbr>ALDH</abbr>/<abbr>ALR</abbr>):</b> <a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine (adrenaline)</a>→DHMA</li>
<li>Metanephrine→MHPG/<a href="Vanillylmandelic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanillylmandelic_acid" title="Vanillylmandelic acid">VMA</a></li>
<li>Norepinephrine (noradrenaline)→DHMA</li>
<li>Normetanephrine→MHPG/<a href="Vanillylmandelic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanillylmandelic_acid" title="Vanillylmandelic acid">VMA</a></li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a>→<a href="3,4-Dihydroxyphenylacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Dihydroxyphenylacetic_acid" title="3,4-Dihydroxyphenylacetic acid">DOPAC</a></li>
<li><a href="3-Methoxytyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a>→<a href="Homovanillic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Homovanillic_acid" title="Homovanillic acid">HVA</a></li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a>→<a href="5-Hydroxyindoleacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Hydroxyindoleacetic_acid" title="5-Hydroxyindoleacetic acid">5-HIAA</a></li></ul>

<ul><li><b>Inhibitors:</b> <i>Non-selective:</i> Benmoxin</li>
<li>Caroxazone</li>
<li>Echinopsidine</li>
<li><a href="Furazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazolidone" title="Furazolidone">Furazolidone</a></li>
<li>Guineesine</li>
<li><a href="Hydralazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydralazine" title="Hydralazine">Hydralazine</a></li>
<li>Indantadol</li>
<li>Iproclozide</li>
<li><a href="Iproniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Iproniazid" title="Iproniazid">Iproniazid</a></li>
<li><a href="Isocarboxazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isocarboxazid" title="Isocarboxazid">Isocarboxazid</a></li>
<li><a href="Isoniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoniazid" title="Isoniazid">Isoniazid</a></li>
<li><a href="Linezolid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linezolid" title="Linezolid">Linezolid</a></li>
<li>Mebanazine</li>
<li>Metfendrazine</li>
<li><a href="Nialamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nialamide" title="Nialamide">Nialamide</a></li>
<li>Octamoxin</li>
<li>Paraxazone</li>
<li><a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">Phenelzine</a></li>
<li>Pheniprazine</li>
<li>Phenoxypropazine</li>
<li>Pivhydrazine</li>
<li><a href="Procarbazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procarbazine" title="Procarbazine">Procarbazine</a></li>
<li>Safrazine</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> <i>MAO-A-selective:</i> Amiflamine</li>
<li>Bazinaprine</li>
<li>Befloxatone</li>
<li>Brofaromine</li>
<li>Cimoxatone</li>
<li><a href="Clorgiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Clorgiline" title="Clorgiline">Clorgiline</a></li>
<li>CX157 (Tyrima)</li>
<li>Eprobemide</li>
<li>Esuprone</li>
<li><a href="Harmala_alkaloid.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmala_alkaloid" title="Harmala alkaloid">Harmala alkaloids</a> (e.g., <a href="Harmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmine" title="Harmine">harmine</a>, <a href="Harmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmaline" title="Harmaline">harmaline</a>, harman, norharman, tetrahydroharmine)</li>
<li>Methylene blue</li>
<li>Metralindole</li>
<li><a href="Minaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Minaprine" title="Minaprine">Minaprine</a></li>
<li><a href="Moclobemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Moclobemide" title="Moclobemide">Moclobemide</a></li>
<li>Pirlindole</li>
<li>Sercloremine</li>
<li>Tetrindole</li>
<li>Toloxatone</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> <i>MAO-B selective:</i> <span class="new">Adarigiline</span></li>
<li>Almoxatone</li>
<li><small>D</small>-Deprenyl</li>
<li><a href="Ethanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethanol" title="Ethanol">Ethanol</a></li>
<li>Ladostigil</li>
<li>Lazabemide</li>
<li>Milacemide</li>
<li>Mofegiline</li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li><a href="Pargyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Pargyline" title="Pargyline">Pargyline</a><sup>‡</sup></li>
<li><a href="Rasagiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li>Safinamide</li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline (<small>L</small>-Deprenyl)</a></li>
<li><span class="new">Sembragiline</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Phenethylamines<br><small>(<a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a>, <a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">epinephrine</a>,<br>norepinephrine)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>PAH</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine">Phenylalanine</a>→<a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">Tyrosine</a></li></ul>

<ul><li><b>Inhibitors:</b> 3,4-Dihydroxystyrene</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>TH</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">Tyrosine</a>→<a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a></li></ul>

<ul><li><b>Inhibitors:</b> 2-Hydroxyestradiol</li>
<li>2-Hydroxyestrone</li>
<li>3-Iodotyrosine</li>
<li>Aquayamycin</li>
<li>Bulbocapnine</li>
<li><a href="Metirosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Metirosine" title="Metirosine">Metirosine</a></li>
<li>Oudenone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>DBH</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a>→Norepinephrine (Noradrenaline)</li></ul>

<ul><li><b>Inhibitors:</b> Bupicomide</li>
<li><a href="Disulfiram.htm" tppabs="https://ptable.com/wiki/compounds/A/Disulfiram" title="Disulfiram">Disulfiram</a></li>
<li>Dopastin</li>
<li><a href="Fusaric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Fusaric_acid" title="Fusaric acid">Fusaric acid</a></li>
<li>Nepicastat</li>
<li>Phenopicolinic acid</li>
<li><a href="Tropolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropolone" title="Tropolone">Tropolone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>PNMT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> Norepinephrine (noradrenaline)→<a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine (adrenaline)</a></li></ul>

<ul><li><b>Inhibitors:</b> <span class="new">CGS-19281A</span></li>
<li><span class="new">SKF-64139</span></li>
<li><span class="new">SKF-7698</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>COMT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a>→<a href="3-Methoxytyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a></li>
<li><a href="3,4-Dihydroxyphenylacetic_acid-1.htm" tppabs="https://ptable.com/wiki/compounds/A/DOPAC" title="DOPAC" class="mw-redirect">DOPAC</a>→<a href="Homovanillic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Homovanillic_acid" title="Homovanillic acid">Homovanillic acid</a></li>
<li>Norepinephrine→Normetanephrine</li>
<li><a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine</a>→Metanephrine</li>
<li><a href="Dihydroxyphenylethylene_glycol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroxyphenylethylene_glycol" title="Dihydroxyphenylethylene glycol">DOPEG</a>→MOPEG</li>
<li>DOMA→<a href="Vanillylmandelic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanillylmandelic_acid" title="Vanillylmandelic acid">VMA</a></li>
<li>2-Hydroxyestradiol→<a href="2-Methoxyestradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Methoxyestradiol" title="2-Methoxyestradiol">2-Methoxyestradiol</a></li>
<li>2-Hydroxyestrone→2-Methoxyestrone</li>
<li>4-Hydroxyestradiol→4-Methoxyestradiol</li>
<li>4-Hydroxyestrone→4-Methoxyestrone</li></ul>

<ul><li><b>Inhibitors:</b> 2-Hydroxyestradiol</li>
<li>2-Hydroxyestrone</li>
<li><a href="Entacapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Entacapone" title="Entacapone">Entacapone</a></li>
<li><span class="new">Neluxicapone</span></li>
<li><a href="Nitecapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitecapone" title="Nitecapone">Nitecapone</a></li>
<li>Opicapone</li>
<li><a href="Quinalizarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinalizarin" title="Quinalizarin">Quinalizarin</a></li>
<li><a href="Tolcapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolcapone" title="Tolcapone">Tolcapone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Tryptamines<br><small>(<a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">serotonin</a>, <a href="Melatonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Melatonin" title="Melatonin">melatonin</a>)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>TPH</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Tryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptophan" title="Tryptophan">Tryptophan</a>→<a href="5-Hydroxytryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/5-HTP" title="5-HTP" class="mw-redirect">5-HTP</a></li></ul>

<ul><li><b>Inhibitors:</b> AGN-2979</li>
<li><a href="Fenclonine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenclonine" title="Fenclonine">Fenclonine (PCPA)</a></li>
<li>Telotristat ethyl</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>AANAT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a>→<a href="N-Acetylserotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylserotonin" title="N-Acetylserotonin">N-Acetylserotonin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>ASMT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="N-Acetylserotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylserotonin" title="N-Acetylserotonin">N-Acetylserotonin</a>→<a href="Melatonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Melatonin" title="Melatonin">Melatonin</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>HDC</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <small>L</small>-Histidine→<a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li></ul>

<ul><li><b>Inhibitors:</b> <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/(%2B)-Catechin" title="(+)-Catechin" class="mw-redirect">Catechin</a></li>
<li>Alpha-Fluoromethylhistidine</li>
<li>Histidine methyl ester</li>
<li>Meciadanol</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Tritoqualine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>HNMT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a>→<span class="new">N-Methylhistamine</span></li></ul>

<ul><li><b>Inhibitors:</b> <a href="Amodiaquine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amodiaquine" title="Amodiaquine">Amodiaquine</a></li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li><a href="Harmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmaline" title="Harmaline">Harmaline</a></li>
<li><span class="new">Metoprine</span></li>
<li><a href="Quinacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinacrine" title="Quinacrine" class="mw-redirect">Quinacrine</a></li>
<li>SKF-91488</li>
<li><a href="Tacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrine" title="Tacrine">Tacrine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>DAO</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a>→<span class="new">Imidazole acetic acid</span></li></ul>

<ul><li><b>Inhibitors:</b> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Pimagedine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Pimagedine'" tppabs="https://ptable.com/wiki/compounds/A/Pimagedine" title="Pimagedine">Pimagedine (aminoguanidine)</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><small><i><b>See also:</b> Receptor/signaling modulators • Adrenergics • Dopaminergics • Melatonergics • Serotonergics • Monoamine reuptake inhibitors • Monoamine releasing agents • Monoamine neurotoxins</i></small></div></td></tr></tbody></table></div>





<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>